<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JCN</journal-id>
<journal-id journal-id-type="hwp">spjcn</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Neurol</journal-id>
<journal-title>Journal of Child Neurology</journal-title>
<issn pub-type="ppub">0883-0738</issn>
<issn pub-type="epub">1708-8283</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0883073811428377</article-id>
<article-id pub-id-type="publisher-id">10.1177_0883073811428377</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Topical Review Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Fetal Alcohol Spectrum Disorders—Implications for Child Neurology, Part 2: Diagnosis and Management</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Paintner</surname>
<given-names>Ashley</given-names>
</name>
<degrees>BA</degrees>
<xref ref-type="aff" rid="aff1-0883073811428377">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Williams</surname>
<given-names>Andrew D.</given-names>
</name>
<degrees>MPH</degrees>
<xref ref-type="aff" rid="aff1-0883073811428377">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Burd</surname>
<given-names>Larry</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0883073811428377">1</xref>
<xref ref-type="corresp" rid="corresp1-0883073811428377"/>
</contrib>
</contrib-group>
<aff id="aff1-0883073811428377">
<label>1</label>North Dakota Fetal Alcohol Syndrome Center, Department of Pediatrics, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA</aff>
<author-notes>
<corresp id="corresp1-0883073811428377">Larry Burd, PhD, North Dakota Fetal Alcohol Syndrome Center, 501 North Columbia Rd, Stop 9037, Grand Forks, ND 58203-9037 Email: <email>larry.burd@med.und.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>3</issue>
<fpage>355</fpage>
<lpage>362</lpage>
<history>
<date date-type="received">
<day>8</day>
<month>8</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>6</day>
<month>10</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>In part 1, we discussed the mechanism of alcohol exposure, dosimetry, and the teratogenic pathways of damage to the fetus. In part 2, we review the diagnosis of fetal alcohol spectrum disorders and the developmental implications of prenatal alcohol exposure. Fetal alcohol spectrum disorders are associated with increased rates of mental retardation, seizure disorders, brain malformations, and premature mortality. The risk of comorbid disorders is increased among this population, which enhances phenotype severity and complexity of management. Recurrence rates are high and younger siblings tend to be more severely affected. Detection of prenatal alcohol use warrants substance abuse intervention, which can avoid exposure in subsequent pregnancies. Fetal alcohol spectrum disorders are common developmental disorders with a phenotype that is influenced by both age and development and require long-term management. Child neurologists are essential in the diagnosis and management of fetal alcohol spectrum disorders.</p>
</abstract>
<kwd-group>
<kwd>fetal alcohol spectrum disorders</kwd>
<kwd>diagnosis</kwd>
<kwd>management</kwd>
<kwd>prevalence</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>In part 1 of this series, we discussed the role of the placental-umbilical unit in the dispersal mechanisms of ethanol into and out of the fetal compartment. We also reviewed the mechanisms of alcohol elimination from the fetus and mechanisms of the toxicokinetic effects of ethanol exposure in the fetus with an emphasis on development of brain abnormalities. In this paper, we review the diagnostic criteria for fetal alcohol spectrum disorders, the course of fetal alcohol spectrum disorders, management from infancy through adolescence, cost of care, and prevention strategies.</p>
<sec id="section1-0883073811428377">
<title>Discussion</title>
<sec id="section2-0883073811428377">
<title>Diagnosis</title>
<p>Children with fetal alcohol spectrum disorders typically present with delays, birth defects, a history of placement in foster care or adoptive homes, and whose mother has been in substance abuse treatment or in the corrections system. The initial diagnosis should be confirmed as early as possible, as early diagnosis and entry into intervention programs is associated with improved outcomes.<sup>
<xref ref-type="bibr" rid="bibr1-0883073811428377">1</xref>
</sup>
</p>
<p>Fetal alcohol spectrum disorders are composed of 4 diagnostic categories: (1) fetal alcohol syndrome; (2) partial fetal alcohol syndrome; (3) alcohol-related neurodevelopmental disorders; and (4) alcohol-related birth defects. Multiple diagnostic criteria are available.<sup>
<xref ref-type="bibr" rid="bibr2-0883073811428377">2</xref>
<xref ref-type="bibr" rid="bibr3-0883073811428377"/>
<xref ref-type="bibr" rid="bibr4-0883073811428377"/>–<xref ref-type="bibr" rid="bibr5-0883073811428377">6</xref>
</sup> While the criteria have considerable overlap, guidance for clinicians in the selection of optimal criteria has been limited by a lack of comparison studies to evaluate the epidemiologic performance criteria for specificity, sensitivity, and accuracy.<sup>
<xref ref-type="bibr" rid="bibr6-0883073811428377">6</xref>
</sup> Diagnostic criteria from Burd et al and Hoyme are presented in <xref ref-type="table" rid="table1-0883073811428377">Table 1</xref>.<sup>
<xref ref-type="bibr" rid="bibr3-0883073811428377">3</xref>,<xref ref-type="bibr" rid="bibr6-0883073811428377">6</xref>
</sup> Currently, no diagnostic criteria are available for a prenatal diagnosis of fetal alcohol spectrum disorders.</p>
<table-wrap id="table1-0883073811428377" position="float">
<label>Table 1.</label>
<caption>
<p>Criteria For Fetal Alcohol Spectrum Disorders: Revised from Hoyme et al.<sup>
<xref ref-type="bibr" rid="bibr3-0883073811428377">3</xref>
</sup>
</p>
</caption>
<graphic alternate-form-of="table1-0883073811428377" xlink:href="10.1177_0883073811428377-table1.tif"/>
<table>
<tbody>
<tr>
<td>
<bold>Fetal Alcohol Syndrome With Confirmed Maternal Alcohol Exposure (requires all features A-D)</bold>
<list list-type="alpha-upper">
<list-item>
<p>Confirmed maternal alcohol exposure</p>
</list-item>
<list-item>
<p>Evidence of a characteristic pattern of minor facial anomalies, including ≥2 of the following<list list-type="order">
<list-item>
<p>Short palpebral fissures (≤10th percentile)</p>
</list-item>
<list-item>
<p>Thin vermillion border of the upper lip (score 4 or 5 with the lip/philtrum guide)</p>
</list-item>
<list-item>
<p>Smooth philtrum (score 4 or 5 with the lip/philtrum guide)</p>
</list-item>
</list>
</p>
</list-item>
<list-item>
<p>Evidence of prenatal and/or postnatal growth retardation<list list-type="order">
<list-item>
<p>Height or weight ≤10th percentile, corrected for racial norms, if possible</p>
</list-item>
</list>
</p>
</list-item>
<list-item>
<p>Evidence of deficient brain growth or abnormal morphogenesis, including ≥1 of the following<list list-type="order">
<list-item>
<p>Structural brain abnormalities</p>
</list-item>
<list-item>
<p>Head circumference ≤10th percentile</p>
</list-item>
</list>
</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td>
<bold>Fetal Alcohol Syndrome Without Confirmed Maternal Alcohol Exposure</bold>  B, C, and D, as above</td>
</tr>
<tr>
<td>
<bold>Partial Fetal Alcohol Syndrome With Confirmed Maternal Alcohol Exposure (requires all features, A-C)</bold>
<list list-type="alpha-upper">
<list-item>
<p>Confirmed maternal alcohol exposure</p>
</list-item>
<list-item>
<p>Evidence of a characteristic pattern of minor facial anomalies, including ≥2 of the following<list list-type="order">
<list-item>
<p>Short palpebral fissures (≤10th percentile)</p>
</list-item>
<list-item>
<p>Thin vermillion border of the upper lip (score 4 or 5 with the lip/philtrum guide)</p>
</list-item>
<list-item>
<p>Smooth philtrum (score 4 or 5 with the lip/philtrum guide)</p>
</list-item>
</list>
</p>
</list-item>
<list-item>
<p>Evidence of prenatal and/or postnatal growth retardation<list list-type="order">
<list-item>
<p>Height or weight ≤10th percentile, corrected for racial norms, if possible</p>
</list-item>
<list-item>
<p>Evidence of deficient brain growth or abnormal morphogenesis, including ≥1 of the following<list list-type="alpha-lower">
<list-item>
<p>Structural brain abnormalities</p>
</list-item>
<list-item>
<p>Head circumference ≤10th percentile</p>
</list-item>
</list>
</p>
</list-item>
</list>
</p>
</list-item>
<list-item>
<p>Evidence of a complex patter of behavioral or cognitive abnormalities inconsistent with developmental level that cannot by explained by genetic predisposition, family background, or environment alone.<list list-type="alpha-lower">
<list-item>
<p>This pattern includes marked impairment in the performance of complex tasks (complex problem solving, planning, judgment, abstraction, metacognition, and arithmetic tasks); higher-level receptive and expressive language deficits; and disordered behavior (difficulties in personal manner, emotional ability, motor dysfunction, poor academic performance, and deficient social interaction)</p>
</list-item>
</list>
</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td>
<bold>Partial Fetal Alcohol Syndrome Without Confirmed Maternal Alcohol Exposure</bold>  B and C, as above</td>
</tr>
<tr>
<td>
<bold>Alcohol Related Neurodevelopmental Disorder (ARND)</bold> <bold>(requires both A and B)</bold>
<list list-type="alpha-upper">
<list-item>
<p>Confirmed maternal alcohol exposure</p>
</list-item>
<list-item>
<p>At least 1 of the following<list list-type="order">
<list-item>
<p>Evidence of deficient brain growth or abnormal morphogenesis, including ≥1 of the following<list list-type="alpha-lower">
<list-item>
<p>Structural brain abnormalities</p>
</list-item>
<list-item>
<p>Head circumference ≤10th percentile</p>
</list-item>
</list>
</p>
</list-item>
<list-item>
<p>Evidence of a complex pattern of behavioral or cognitive abnormalities inconsistent with developmental level that cannot be explained by genetic predisposition, family background, or environment alone<list list-type="alpha-lower">
<list-item>
<p>This pattern includes marked impairment in the performance of complex tasks (complex problem solving, planning, judgment, abstraction, metacognition, and arithmetic tasks); higher-level receptive and expressive language deficits; and disordered behavior (difficulties in personal manner, emotional ability, motor dysfunction, poor academic performance, and deficient social interaction)</p>
</list-item>
</list>
</p>
</list-item>
</list>
</p>
</list-item>
</list>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The diagnosis of Fetal Alcohol Syndrome requires the presence of growth impairment, central nervous system damage and/or impairment, and at least 2 characteristic facial features. Current criteria utilize the 10th percentile as a cutoff for growth impairments for either height or weight, which can be assessed by evidence of past growth impairment at birth, during infancy, or during childhood. Growth impairment is not stable and often attenuates during childhood and especially during adolescence.<sup>
<xref ref-type="bibr" rid="bibr8-0883073811428377">8</xref>
</sup> Figure l depicts the adverse developmental outcomes of fetal alcohol spectrum disorder. Characteristic facial features can be seen in <xref ref-type="fig" rid="fig2-0883073811428377">Figure 2</xref>.</p>
<fig id="fig1-0883073811428377" position="float">
<label>Figure 1.</label>
<caption>
<p>Developmental window for common impairments and comorbid conditions in fetal alcohol spectrum disorders.</p>
</caption>
<graphic alternate-form-of="fig1-0883073811428377" xlink:href="10.1177_0883073811428377-fig1.tif"/>
</fig>
<fig id="fig2-0883073811428377" position="float">
<label>Figure 2. </label>
<caption>
<p>Characteristic facial features in fetal alcohol spectrum disorders.</p>
</caption>
<graphic alternate-form-of="fig2-0883073811428377" xlink:href="10.1177_0883073811428377-fig2.tif"/>
</fig>
<p>Evidence of central nervous system dysfunction is determined by the presence of an abnormal neurologic examination, imaging of structural abnormalities, or deficits identified by neuropsychological evaluation.<sup>
<xref ref-type="bibr" rid="bibr9-0883073811428377">9</xref>
</sup> Currently a 1.5 to 2 standard deviation deficit in 2 or more neuropsychologic functions are considered to be evidence of central nervous system damage consistent with prenatal alcohol exposure. The evaluation protocol is age and development dependent. For example, diagnosis of developmental disorders is difficult in early infancy but becomes much more identifiable as development proceeds. The developmental window for common impairments associated with fetal alcohol spectrum disorder continues through adolescence and into adult life (<xref ref-type="fig" rid="fig1-0883073811428377">Figure 1</xref>). A multidisciplinary approach is recommended for the initial evaluation.</p>
<p>Most cases of fetal alcohol spectrum disorders are identified when the infant has reached a developmental stage to allow for an accurate neuropsychological assessment of delayed development. This time window is considered optimal from 2 through 16 years of age.<sup>
<xref ref-type="bibr" rid="bibr10-0883073811428377">10</xref>
</sup> While fetal alcohol spectrum disorders can be identified at birth or during infancy, only the most severe cases typically are diagnosed during this time period, and high rates of false negatives have been reported.<sup>
<xref ref-type="bibr" rid="bibr11-0883073811428377">11</xref>
</sup> The optimal developmental window for assessment occurs when it is possible to evaluate cognitive development, speech and language development, attention, fine and gross motor skills, and other aspects of delayed or aberrant neuropsychological functioning. Imaging studies are not a routine component of evaluation unless clinically indicated.<sup>
<xref ref-type="bibr" rid="bibr10-0883073811428377">10</xref>
</sup>
</p>
<p>Very limited information is currently available on the diagnosis of fetal alcohol spectrum disorders in adults and middle-age populations, and published studies of fetal alcohol spectrum disorders in the elderly do not yet exist. The current diagnostic criteria for fetal alcohol spectrum disorders have significant limitations when used with adults. This is relevant when considering fetal alcohol spectrum disorders in the parents of an affected child with a fetal alcohol spectrum disorder. In some cases, retrieval of prenatal care records and pictures during early childhood can facilitate an accurate diagnosis.</p>
</sec>
<sec id="section3-0883073811428377">
<title>Exposure Assessment</title>
<p>We reviewed the issue of assessing exposure in detail in part 1 of this series. However, since this is an exposure-dependent diagnosis, we briefly summarize the relevant concepts. Most people with a fetal alcohol spectrum disorder (70%-80%) have early separation from their parents (foster care, adoption, maternal death or incarceration), compounding problems of confirmation of prenatal alcohol exposure and the assessment of dosimetry.<sup>
<xref ref-type="bibr" rid="bibr1-0883073811428377">1,13</xref>
</sup> A specific history of prenatal alcohol exposure is useful but not required for a diagnosis of fetal alcohol syndrome. However, confirmation of exposure (maternal reports or data from a knowledgeable informant) is required for the diagnoses of both alcohol-related neurodevelopmental disorder  and alcohol-related birth defects.</p>
</sec>
<sec id="section4-0883073811428377">
<title>Prevalence Rates of Fetal Alcohol Spectrum Disorders</title>
<p>Current prevalence estimates for fetal alcohol spectrum disorders range from 0.3 (fetal alcohol syndrome only) to 9.1 total cases of fetal alcohol spectrum disorders per 1000 live births or about 109 new cases each day in the United States.<sup>
<xref ref-type="bibr" rid="bibr5-0883073811428377">5</xref>,<xref ref-type="bibr" rid="bibr6-0883073811428377">6</xref>,<xref ref-type="bibr" rid="bibr12-0883073811428377">12</xref>,<xref ref-type="bibr" rid="bibr13-0883073811428377">13</xref>
</sup> Recent school-based prevalence studies using active case ascertainment strategies followed by comprehensive multidisciplinary evaluations have identified fetal alcohol spectrum disorder prevalence rate of 1% to 2%.<sup>
<xref ref-type="bibr" rid="bibr14-0883073811428377">14</xref>,<xref ref-type="bibr" rid="bibr15-0883073811428377">15</xref>
</sup> In some populations, the rates of fetal alcohol spectrum disorder may be as prevalent as 10 to 89 per 1000.<sup>
<xref ref-type="bibr" rid="bibr7-0883073811428377">7</xref>,<xref ref-type="bibr" rid="bibr8-0883073811428377">14,16–18</xref>
</sup> Fetal alcohol spectrum disorders are even more prevalent in certain at-risk populations; prevalence studies conducted in Western Cape, South Africa, found a fetal alcohol spectrum disorder rate of 4% to 8%.<sup>
<xref ref-type="bibr" rid="bibr16-0883073811428377">16</xref>
<xref ref-type="bibr" rid="bibr17-0883073811428377"/>–<xref ref-type="bibr" rid="bibr18-0883073811428377">18</xref>
</sup> Thus, fetal alcohol spectrum disorder is one of the most common developmental disorders and may be the most identifiable known cause of mental retardation in the world.</p>
<p>The current prevalence estimates suggest that a significantly small number of people with fetal alcohol spectrum disorders are identified. In the United States, it is likely that several hundred thousand children and adolescents with fetal alcohol spectrum disorders are undiagnosed and rates would be expected to be high in children in foster care, residential care, juvenile corrections facilities, birth defect clinics, or those who present with neuropsychological impairments. Diagnosis of a fetal alcohol spectrum disorder  would also be relevant in infant and child mortality reviews, since the mortality risk increases with this diagnosis.<sup>
<xref ref-type="bibr" rid="bibr19-0883073811428377">19</xref>
</sup> Prenatal alcohol exposure is associated with increased risk for preterm delivery.<sup>
<xref ref-type="bibr" rid="bibr20-0883073811428377">20</xref>
</sup>
</p>
</sec>
<sec id="section5-0883073811428377">
<title>Comorbidity</title>
<p>In our clinic, we have evaluated more than 600 infants and children with fetal alcohol spectrum disorders and followed many over the past 30 years. We have found comorbidity to be an important issue in the lives of most people with this diagnosis, especially as they mature into adolescence and adulthood. In <xref ref-type="fig" rid="fig3-0883073811428377">Figure 3</xref> we present a model of comorbidity and the potential effects on development. An often underappreciated aspect of fetal alcohol spectrum disorders is phenotype modification, where fetal alcohol spectrum disorders increase the severity or complexity of other conditions (ie, Rett syndrome, autism, schizophrenia, Noonan syndrome).<sup>
<xref ref-type="bibr" rid="bibr21-0883073811428377">21</xref>
</sup> In our experience, comorbidity is an important clinical issue in diagnosis and substantially increases the complexity of management over time. The most common comorbid conditions are listed by developmental time frame in <xref ref-type="fig" rid="fig1-0883073811428377">Figure 1</xref>. This dictates the need for longitudinal follow-up of fetal alcohol spectrum disorders through infancy and into adult life.</p>
<fig id="fig3-0883073811428377" position="float">
<label>Figure 3. </label>
<caption>
<p>Fetal alcohol spectrum disorders: outcomes from prenatal exposure.</p>
<p>Note: ADHD = attention-deficit hyperactivity disorder.</p>
</caption>
<graphic alternate-form-of="fig3-0883073811428377" xlink:href="10.1177_0883073811428377-fig3.tif"/>
</fig>
</sec>
<sec id="section6-0883073811428377">
<title>Recurrence Risk</title>
<p>The recurrence rates of fetal alcohol spectrum disorders are high and are currently thought to exceed 50% and may approach 75%, if mothers continue to drink in subsequent pregnancies.<sup>
<xref ref-type="bibr" rid="bibr10-0883073811428377">10</xref>,<xref ref-type="bibr" rid="bibr22-0883073811428377">22</xref>
<xref ref-type="bibr" rid="bibr23-0883073811428377"/>–<xref ref-type="bibr" rid="bibr24-0883073811428377">24</xref>
</sup> In sibships, younger children are at greater risk than older siblings and manifest increased syndrome severity, presumably because of increasing severity of alcoholism over time.<sup>
<xref ref-type="bibr" rid="bibr24-0883073811428377">24</xref>
</sup> This highlights the need for assessment of all siblings of a child who has been diagnosed with a fetal alcohol spectrum disorder, even if they are in alternative placements or have been adopted. In addition, there is a strong transgenerational risk of fetal alcohol spectrum disorders.<sup>
<xref ref-type="bibr" rid="bibr22-0883073811428377">22</xref>,<xref ref-type="bibr" rid="bibr23-0883073811428377">23</xref>
</sup>
</p>
</sec>
<sec id="section7-0883073811428377">
<title>Mortality</title>
<p>Mortality risks (miscarriage, stillbirth, etc) associated with prenatal alcohol exposure are ongoing throughout pregnancy.<sup>
<xref ref-type="bibr" rid="bibr19-0883073811428377">19</xref>
</sup> Ethanol exposure impairs fertility, decreases implantations, increases miscarriages, and is associated with a 4-fold increase in stillbirths and mortality throughout childhood.<sup>
<xref ref-type="bibr" rid="bibr25-0883073811428377">25</xref>
</sup> Four- to 10-fold increases in rates of sudden infant death syndrome are associated with prenatal alcohol exposure.<sup>
<xref ref-type="bibr" rid="bibr26-0883073811428377">26</xref>,<xref ref-type="bibr" rid="bibr27-0883073811428377">27</xref>
</sup> An increased mortality rate among siblings of children with fetal alcohol spectrum disorders is present, even if their fetal alcohol spectrum disorder diagnostic status in unknown.<sup>
<xref ref-type="bibr" rid="bibr28-0883073811428377">28</xref>
</sup> In addition, studies have reported an increased mortality among mothers of children with fetal alcohol spectrum disorder.<sup>
<xref ref-type="bibr" rid="bibr23-0883073811428377">23</xref>,<xref ref-type="bibr" rid="bibr29-0883073811428377">29</xref>
<xref ref-type="bibr" rid="bibr30-0883073811428377"/>–<xref ref-type="bibr" rid="bibr31-0883073811428377">31</xref>
</sup> This highlights the need for comprehensive clinical and public health programs to improve early identification of alcohol use during pregnancy, enhance entry and performance of substance abuse treatment programs, prevent the recurrence of exposure in subsequent pregnancies, and decrease postnatal risk associated with parental alcohol abuse for infants and children.</p>
</sec>
<sec id="section8-0883073811428377">
<title>Developmental Course</title>
<sec id="section9-0883073811428377">
<title>Infancy</title>
<p>High rates of vision and hearing disorders, seizures, and abnormal electroencephalography results are common.<sup>
<xref ref-type="bibr" rid="bibr32-0883073811428377">32</xref>
<xref ref-type="bibr" rid="bibr33-0883073811428377"/>–<xref ref-type="bibr" rid="bibr34-0883073811428377">34</xref>
</sup> Surprisingly, data on the prevalence of alcohol withdrawal syndrome in infants is limited. The available studies have reported a relatively mild withdrawal symptomatology for children with fetal alcohol spectrum disorders, including characteristics such as jitteriness, increased respiratory rates, hyperacusis, exaggerated reflexes, and sleep disturbances.<sup>
<xref ref-type="bibr" rid="bibr21-0883073811428377">21</xref>
</sup>
</p>
</sec>
<sec id="section10-0883073811428377">
<title>Childhood and adolescence</title>
<p>By adolescence and early adulthood, high rates of mental retardation, neurocognitive impairment, substance use, impaired peer relationships, increased vulnerability to exploitation, and deficits in judgment and decision making are widely expressed. These adverse outcomes have serious life consequences, leading to school failure, multiple foster home placements, peer exploitation, and frequent contact with law enforcement. Fetal alcohol spectrum disorders appear to have a very long developmental window, extending at least to age thirty. Streissguth and colleagues evaluated 415 patients, ranging in age from 6 to 51 years, diagnosed with either fetal alcohol syndrome or fetal alcohol effects and found increased lifetime prevalence of adverse outcomes (<xref ref-type="table" rid="table2-0883073811428377">Table 2</xref>).<sup>
<xref ref-type="bibr" rid="bibr1-0883073811428377">1</xref>
</sup> Deficits in mathematical calculation and comprehension, and problems with adaptive behavior are common in childhood.<sup>
<xref ref-type="bibr" rid="bibr1-0883073811428377">1</xref>,<xref ref-type="bibr" rid="bibr35-0883073811428377">35</xref>
<xref ref-type="bibr" rid="bibr36-0883073811428377"/>–<xref ref-type="bibr" rid="bibr37-0883073811428377">37</xref>
</sup> Recent follow-up studies of adolescent and adult patients with fetal alcohol spectrum disorders have found high rates of attention-deficit hyperactivity disorder, depression, mental disorders, low rates of independent living, and aberrant decision making.<sup>
<xref ref-type="bibr" rid="bibr10-0883073811428377">10</xref>,<xref ref-type="bibr" rid="bibr38-0883073811428377">38</xref>
</sup>
</p>
<table-wrap id="table2-0883073811428377" position="float">
<label>Table 2.</label>
<caption>
<p>Prevalence of Adverse Outcomes in Fetal Alcohol Spectrum Disorders<sup>1</sup>
</p>
</caption>
<graphic alternate-form-of="table2-0883073811428377" xlink:href="10.1177_0883073811428377-table2.tif"/>
<table>
<thead>
<tr>
<th>Adverse Outcome</th>
<th colspan="3">Prevalence, %, by Age, y, at Interview</th>
</tr>
</thead>
<tbody>
<tr>
<td>
</td>
<td align="center">Age 6-11</td>
<td align="center">Age 12-20</td>
<td align="center">Age 21-51</td>
</tr>
<tr>
<td>Inappropriate sexual behavior</td>
<td>39.1</td>
<td>47.5</td>
<td>51.7</td>
</tr>
<tr>
<td>Disrupted school experiences</td>
<td>14.3</td>
<td>62.3</td>
<td>59.1</td>
</tr>
<tr>
<td>Trouble with the law</td>
<td>14.3</td>
<td>61.1</td>
<td>58.4</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section11-0883073811428377">
<title>Treatment–Intervention Strategies</title>
<p>The brain is the organ most consistently impaired by prenatal alcohol exposure. Thus, child neurologists play a key role in the diagnosis of fetal alcohol spectrum disorders. This role should include determining risk for a fetal alcohol spectrum disorder and managing the multidisciplinary evaluation to identify the multiple comorbid developmental disorders often found in cases with prenatal alcohol exposure. These comorbid disorders often comprise the treatment goals of affected infants and children. The information gathered from careful assessment and the long-term management needs of affected children should be shared with colleagues providing other developmental interventions, such as speech and language therapy, social work, psychological and psychiatric services, special education, occupational therapy, physical therapy, and substance abuse treatment programs.</p>
<p>Developmental assessments and linkage to intervention strategies and resources should begin as early as possible, ideally occurring jointly with diagnosis. These strategies should start with a careful assessment of the home environment, including a systematic inquiry about alcohol and substance abuse and safety of infants in the home environment. Early intervention decreases the likelihood of adverse outcomes. Multiple foster home placements are common and extremely detrimental to development. Early guidance about the severity of these disorders and appropriate interventions may decrease risk for multiple foster home placements and have great potential to improve developmental outcome. It is important to note that the early prenatal environment for children with a fetal alcohol spectrum disorder is often one of exposure to multiple teratogens, including alcohol, smoking, other drug use, inadequate nutrition, high rates of depression, violence, and suboptimal living conditions. It is useful to acknowledge the link between prenatal alcohol exposure and increased risk for postnatal environmental adversity. Persistence of these adverse conditions through childhood and into adolescence increases the risk of abuse, neglect, academic failure, injury, and mortality.</p>
<p>When developing treatment programs, it is imperative that schools, foster homes, and residential care programs understand that the neurobehavioral phenotype of fetal alcohol spectrum disorders is a mix of impairments and behaviors. Behaviors are variably modifiable, and impairments will often require modification of programmatic objectives and psychosocial expectations. Wide fluctuations in day-to-day levels of performance are common in fetal alcohol spectrum disorders and may represent a distinctive neurocognitive feature of fetal alcohol spectrum disorders. This issue often leads to problematic program expectations. The child’s ability to perform a task on one day is often not representative of his or her ability over time, which can lead to unrealistic expectations set on days of peak performance. The attribution of subsequent failure to perform at that level as being due to willful defiance is common. This issue may be more appropriately managed by acknowledging the role of impairments, which are less likely to be improved by intervention but are responsive to accommodation and a more narrow focus on behavior.</p>
<p>A primary goal when working with patients diagnosed with a fetal alcohol spectrum disorder is to provide anticipatory guidance about future developmental abnormalities and to provide appropriate therapeutic interventions. Equally important is a long-term plan that includes prospective risk reduction. Three common goals are to (1) prevent multiple foster home placements, which are extremely detrimental for optimal development; (2) maximize parent or caretaker understanding of the age-related changes in behavior and age-related risk; and (3) anticipation of future development of age-related impairments common in fetal alcohol spectrum disorders. For example, at our center we use a 10-year plan where at each contact we review current problems and provide anticipatory guidance about potential upcoming issues. During late childhood and adolescence, we emphasize the need to plan for the fetal alcohol spectrum disorder tetrad of peer exploitation, substance abuse, decreased potential for independent living, and increased risk for incarceration.</p>
</sec>
<sec id="section12-0883073811428377">
<title>Pharmacologic Management</title>
<p>For many children with a fetal alcohol spectrum disorder, attention-deficit hyperactivity disorder is an initial presenting problem and early recognition appears to be associated with a positive response to developmental interventions and pharmacologic interventions.<sup>
<xref ref-type="bibr" rid="bibr39-0883073811428377">39</xref>
</sup> In a summary review of use of stimulants, 5 studies reported on 94 subjects. In these studies, 88% (83/94) of the subjects were reported to have a positive response to pharmacologic treatment of attention-deficit hyperactivity disorder.<sup>
<xref ref-type="bibr" rid="bibr39-0883073811428377">39</xref>
</sup> However, there is controversy over the appropriate intervention methods used for the treatment of attention-deficit hyperactivity disorder among children with a fetal alcohol spectrum disorder.<sup>
<xref ref-type="bibr" rid="bibr40-0883073811428377">40</xref>,<xref ref-type="bibr" rid="bibr41-0883073811428377">41</xref>
</sup>
</p>
<p>As development progresses, surveillance for common comorbid disorders such as epilepsy, depression, anxiety disorders, sensory impairments, and cognitive impairments is imperative as early intervention decreases the likelihood of adverse outcomes.<sup>
<xref ref-type="bibr" rid="bibr1-0883073811428377">1</xref>
</sup> Thus, fetal alcohol spectrum disorders are most appropriately considered to be a developmental disorder with a changing phenotype in response to age and development. This suggests that long-term management by knowledgeable providers will be essential for optimal outcomes.</p>
</sec>
<sec id="section13-0883073811428377">
<title>Cost of Care</title>
<p>The public health burden for cases of fetal alcohol spectrum disorder is significant with lifetime costs of care at approximately $2 million to $2.8 million.<sup>
<xref ref-type="bibr" rid="bibr42-0883073811428377">42</xref>
</sup> These rates are similar across the United States and Canada.<sup>
<xref ref-type="bibr" rid="bibr42-0883073811428377">42</xref>,<xref ref-type="bibr" rid="bibr43-0883073811428377">43</xref>
</sup> Several studies have been conducted on prevalence rates and costs associated with fetal alcohol spectrum disorders in South Africa. The rates of fetal alcohol syndrome and partial fetal alcohol syndrome in South Africa are the highest reported worldwide.<sup>
<xref ref-type="bibr" rid="bibr14-0883073811428377">14</xref>,<xref ref-type="bibr" rid="bibr16-0883073811428377">16</xref>,<xref ref-type="bibr" rid="bibr44-0883073811428377">44</xref>,<xref ref-type="bibr" rid="bibr45-0883073811428377">45</xref>
</sup> Subsequently, Crede and colleagues reported that annually $70 960 053 is spent on managing health care needs of children with fetal alcohol syndrome/partial fetal alcohol syndrome  in the Western Cape, South Africa.<sup>
<xref ref-type="bibr" rid="bibr46-0883073811428377">46</xref>
</sup> The burden of care seems disproportionate to the resources spent on prevention.</p>
</sec>
<sec id="section14-0883073811428377">
<title>Prevention</title>
<p>Prevention of fetal alcohol spectrum disorders will require improved screening strategies to detect substance abuse during the early stages of prenatal care. Early diagnosis of alcohol abuse or fetal alcohol spectrum disorder can lead to the prevention of future cases if the mother can enter an effective substance abuse treatment program. Thus, prevention of fetal alcohol spectrum disorders offers an important opportunity to decrease infant, child, and adolescent morbidity and mortality. Similarly, early recognition has the potential to decrease the need for subsequent developmental interventions and reduce the rates of residential placement and entry into substance abuse treatment programs and corrections systems. This would accrue huge cost savings to state and federal governments. Current prevalence estimates in the United States of 40 000 new cases each year suggest that it is likely most child neurologists have and will see large numbers of infants and children with fetal alcohol spectrum disorders throughout their career.</p>
</sec>
</sec>
<sec id="section15-0883073811428377">
<title>Conclusion</title>
<p>The diagnosis and management of fetal alcohol spectrum disorders requires a multifaceted approach. Criteria for diagnosis of fetal alcohol spectrum disorders include growth impairment, varied central nervous system damage, and characteristic facial features collectively requiring a team of clinicians to properly diagnose. Long-term management of fetal alcohol spectrum disorders requires specialized care and therapy. Language and speech therapists, special education services, occupational and physical therapists, psychiatrists, assisted living programs, and substance abuse treatment programs may all be utilized for a child with fetal alcohol spectrum disorder. Many of these services will be needed throughout life, and it is recommended that 10-year management plans are developed to review the current situation and anticipate upcoming problems.</p>
<p>With a prevalence rate of nearly 9.1 cases of fetal alcohol spectrum disorders per 1000 live births, it is likely many children and adolescents are left undiagnosed.<sup>
<xref ref-type="bibr" rid="bibr13-0883073811428377">13</xref>
</sup> Identifying a fetal alcohol spectrum disorder at an early age is essential to providing the best care for the child. Early identification can lead to early enrollment into benefits such as special education and speech and language therapy. Diagnosing a fetal alcohol spectrum disorder early in life also provides the benefit of starting a life-long management plan and coordination of services for the child. Early entrance into services may also reduce the risk of substance abuse, contact with the corrections system, and other adverse outcomes later in life.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1-0883073811428377">
<p>AP and LB are responsible for the main design and concept of this article. AP is responsible for the literature review. AP, ADW, and LB all contributed important intellectual content to this article.</p>
</fn>
<fn fn-type="conflict" id="fn2-0883073811428377">
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. </p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-0883073811428377">
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: this research was supported by NICHD/NIAAA grants 2U01HD045935-08 and 2U01HD045935-09, and North Dakota Department of Health and Human Services grant G11.054.</p>
</fn>
<fn fn-type="other" id="fn4-0883073811428377">
<p>The Institutional Review Board of the University of North Dakota has approved the research cited in this review.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0883073811428377">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Streissguth</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Bookstein</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Barr</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Sampson</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>O'Malley</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>JK</given-names>
</name>
</person-group>. <article-title>Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects</article-title>. <source>J Dev Behav Pediatr</source>. <year>2004</year>;<volume>25</volume>(<issue>4</issue>):<fpage>228</fpage>–<lpage>238</lpage>.</citation>
</ref>
<ref id="bibr2-0883073811428377">
<label>2</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Stratton</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Howe</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>FC</given-names>
</name>
</person-group>, <comment>Institute</comment>
<comment> of Medicine</comment>. <source>Fetal Alcohol Syndrome—Diagnosis, Epidemiology, Prevention, and Treatment</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National</publisher-name>
<publisher-name> Academy</publisher-name>
<publisher-name> Press</publisher-name>; <year>1996</year>.</citation>
</ref>
<ref id="bibr3-0883073811428377">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoyme</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>May</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Kalberg</surname>
<given-names>WO</given-names>
</name>
<etal/>
</person-group>. <article-title>A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 institute of medicine criteria</article-title>. <source>Pediatrics</source>. <year>2005</year>;<volume>115</volume>(<issue>1</issue>):<fpage>39</fpage>–<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr4-0883073811428377">
<label>4</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Astley</surname>
<given-names>SJ</given-names>
</name>
</person-group>, <article-title>Clarren SK</article-title>. <source>Diagnostic Guide for Fetal Alcohol Syndrome and Related Conditions: The 4-Digit Diagnostic Code</source>. <volume>Vol 2</volume>. <publisher-loc>Seattle</publisher-loc>: <publisher-name>University</publisher-name>
<publisher-name> of Washington</publisher-name>; <year>1999</year>.</citation>
</ref>
<ref id="bibr5-0883073811428377">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chudley</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Kilgour</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Cranston</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Challenges of diagnosis in fetal alcohol syndrome and fetal alcohol spectrum disorder in the adult</article-title>. <source>Am J Med Genet C Semin Med Genet</source>. <year>2007</year>;<volume>145</volume>(<issue>3</issue>):<fpage>261</fpage>–<lpage>272</lpage>.</citation>
</ref>
<ref id="bibr6-0883073811428377">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burd</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Klug</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Diagnosis of fetal alcohol spectrum disorders: a validity study of the fetal alcohol syndrome checklist</article-title>. <source>Alcohol</source>. <year>2010</year>;<volume>44</volume>:<fpage>605</fpage>–<lpage>614</lpage>.</citation>
</ref>
<ref id="bibr7-0883073811428377">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Astley</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Clarren</surname>
<given-names>SK</given-names>
</name>
</person-group>. <article-title>Diagnosing the full spectrum of fetal alcohol-exposed individuals: introducing the 4-digit diagnostic code</article-title>. <source>Alcohol Alcohol</source>. <year>2000</year>;<volume>35</volume>:<fpage>400</fpage>–<lpage>410</lpage>.</citation>
</ref>
<ref id="bibr8-0883073811428377">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burd</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Klug</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Martsolf</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ebertowski</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Body mass index in fetal alcohol syndrome</article-title>. <source>Neurotoxicol Teratol</source>. <year>2003</year>;<volume>25</volume>(<issue>6</issue>):<fpage>689</fpage>–<lpage>696</lpage>.</citation>
</ref>
<ref id="bibr9-0883073811428377">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riley</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>McGee</surname>
<given-names>CL</given-names>
</name>
</person-group>, <article-title>Sowell ER. Teratogenic effects of alcohol: a decade of brain imaging</article-title>. <source>Am J Med Genet C Semin Med Genet</source>.  <year>2004</year>;<volume>127C</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr10-0883073811428377">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burd</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cotsonas-Hassler</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Martsolf</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kerbeshian</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Recognition and management of fetal alcohol syndrome</article-title>. <source>Neurotoxicol Teratol</source>. <year>2003</year>;<volume>25</volume>(<issue>6</issue>):<fpage>681</fpage>–<lpage>688</lpage>.</citation>
</ref>
<ref id="bibr11-0883073811428377">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Little</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Snell</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>CR</given-names>
</name>
<etal/>
</person-group>. <article-title>Failure to recognize fetal alcohol syndrome in newborn infants</article-title>. <source>Am J Dis Child</source>. <year>1990</year>;<volume>144</volume>(<issue>10</issue>):<fpage>1142</fpage>–<lpage>1146</lpage>.</citation>
</ref>
<ref id="bibr12-0883073811428377">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herrick</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Burd</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>The Elephant in the cradle</article-title>. <source>Zero to Three Journal</source>. <year>2011</year>;<volume>31</volume>(<issue>3</issue>):<fpage>44</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr13-0883073811428377">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burd</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Klug</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Kerbeshian</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Martsolf</surname>
<given-names>JT</given-names>
</name>
</person-group>. <article-title>Diagnosis of fetal alcohol spectrum disorders: a validity study of the fetal alcohol syndrome checklist</article-title>. <source>Alcohol</source>. <year>2010</year>;<volume>44</volume>(<issue>7-8</issue>):<fpage>605</fpage>–<lpage>614</lpage>.</citation>
</ref>
<ref id="bibr14-0883073811428377">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>May</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Gossage</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Kalberg</surname>
<given-names>WO</given-names>
</name>
<etal/>
</person-group>. <article-title>Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies</article-title>. <source>Dev Disabil Res Rev</source>. <year>2009</year>;<volume>15</volume>(<issue>3</issue>):<fpage>176</fpage>–<lpage>192</lpage>.</citation>
</ref>
<ref id="bibr15-0883073811428377">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poitra</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Marion</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dionne</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>A school based screening program for fetal alcohol syndrome</article-title>. <source>Neurotoxicol Teratol</source>. <year>2003</year>;<volume>25</volume>(<issue>6</issue>):<fpage>725</fpage>–<lpage>729</lpage>.</citation>
</ref>
<ref id="bibr16-0883073811428377">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>May</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Gossage</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Marais</surname>
<given-names>AS</given-names>
</name>
<etal/>
</person-group>. <article-title>The epidemiology of fetal alcohol syndrome and partial FAS in a South African community</article-title>. <source>Drug Alcohol Depend</source>. <year>2007</year>;<volume>88</volume>(<issue>2-3</issue>):<fpage>259</fpage>–<lpage>271</lpage>.</citation>
</ref>
<ref id="bibr17-0883073811428377">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>May</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Goodhart</surname>
<given-names>KA</given-names>
</name>
<etal/>
</person-group>. <article-title>Enhanced case management to prevent fetal alcohol spectrum disorders in Northern Plains communities</article-title>. <source>Matern Child Health J</source>. <year>2008</year>;<volume>12</volume>:<fpage>747</fpage>–<lpage>759</lpage>.</citation>
</ref>
<ref id="bibr18-0883073811428377">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viljoen</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Gossage</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Brooke</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Fetal alcohol syndrome epidemiology in a South African community: a second study of a very high prevalence area</article-title>. <source>J Stud Alcohol</source>. <year>2005</year>;<volume>66</volume>(<issue>5</issue>):<fpage>593</fpage>–<lpage>604</lpage>.</citation>
</ref>
<ref id="bibr19-0883073811428377">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burd</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Fetal, infant, and child mortality in a context of alcohol use</article-title>. <source>Am J Med Genet C Semin Med Genet</source>. <year>2004</year>;<volume>127</volume>(<issue>1</issue>):<fpage>51</fpage>–<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr20-0883073811428377">
<label>20</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Abel</surname>
<given-names>EL</given-names>
</name>
</person-group>. <source>Fetal Alcohol Abuse Syndrome</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Plenum Press</publisher-name>; <year>1998</year>.</citation>
</ref>
<ref id="bibr21-0883073811428377">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burd</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kerbeshian</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Fetal alcohol spectrum disorders and mental illness</article-title>. <source>Int J Disabil Human Dev</source>. <year>2007</year>;<volume>6</volume>(<issue>4</issue>):<fpage>383</fpage>–<lpage>396</lpage>.</citation>
</ref>
<ref id="bibr22-0883073811428377">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kvigne</surname>
<given-names>VL</given-names>
</name>
<name>
<surname>Leonardson</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Neff-Smith</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brock</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Borzelleca</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Welty</surname>
<given-names>TK</given-names>
</name>
</person-group>. <article-title>Characteristics of children who have full or incomplete fetal alcohol syndrome</article-title>. <source>J Pediatr</source>. <year>2004</year>;<volume>145</volume>(<issue>5</issue>):<fpage>635</fpage>–<lpage>640</lpage>.</citation>
</ref>
<ref id="bibr23-0883073811428377">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kvigne</surname>
<given-names>VL</given-names>
</name>
<name>
<surname>Leonardson</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Borzelleca</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Brock</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Neff-Smith</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Welty</surname>
<given-names>TK</given-names>
</name>
</person-group>. <article-title>Characteristics of mothers who have children with fetal alcohol syndrome or some characteristics of fetal alcohol syndrome</article-title>. <source>J Am Board Fam Pract</source>. <year>2003</year>;<volume>16</volume>(<issue>4</issue>):<fpage>296</fpage>–<lpage>303</lpage>.</citation>
</ref>
<ref id="bibr24-0883073811428377">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abel</surname>
<given-names>EL</given-names>
</name>
</person-group>. <article-title>Fetal alcohol syndrome in families</article-title>. <source>Neurotoxicol Teratol</source>. <year>1988</year>;<volume>10</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>2</lpage>.</citation>
</ref>
<ref id="bibr25-0883073811428377">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burd</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Odendaal</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Ethanol and the placenta: a review</article-title>. <source>J Matern Fetal Neonatal Med</source>. <year>2007</year>;<volume>20</volume>(<issue>5</issue>):<fpage>361</fpage>–<lpage>375</lpage>.</citation>
</ref>
<ref id="bibr26-0883073811428377">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iyasu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Randall</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Welty</surname>
<given-names>TK</given-names>
</name>
<etal/>
</person-group>. <article-title>Risk factors for sudden infant death syndrome among northern plains Indians</article-title>. <source>JAMA</source>. <year>2002</year>;<volume>288</volume>(<issue>21</issue>):<fpage>2717</fpage>–<lpage>2723</lpage>.</citation>
</ref>
<ref id="bibr27-0883073811428377">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phillips</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Brewer</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Wadensweiler</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Alcohol as a risk factor for sudden infant death syndrome (SIDS)</article-title>. <source>Addiction</source>. <year>2010</year>;<volume>106</volume>(<issue>3</issue>):<fpage>516</fpage>–<lpage>525</lpage>.</citation>
</ref>
<ref id="bibr28-0883073811428377">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burd</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Klug</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Bueling</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Mortality rates in subjects with fetal alcohol spectrum disorders and their siblings</article-title>. <source>Birth Defects Res A Clin Mol Teratol</source>. <year>2008</year>;<volume>82</volume>(<issue>4</issue>):<fpage>217</fpage>–<lpage>223</lpage>.</citation>
</ref>
<ref id="bibr29-0883073811428377">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berg</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Coles</surname>
<given-names>CD</given-names>
</name>
</person-group>. <article-title>Increased mortality among women who drank alcohol during pregnancy</article-title>. <source>Alcohol</source>. <year>2008</year>;<volume>42</volume>(<issue>7</issue>):<fpage>603</fpage>–<lpage>610</lpage>.</citation>
</ref>
<ref id="bibr30-0883073811428377">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Astley</surname>
<given-names>SJ</given-names>
</name>
</person-group>. <article-title>Profile of the first 1,400 patients receiving diagnostic evaluations for fetal alcohol spectrum disorder at the Washington State Fetal Alcohol Syndrome Diagnostic &amp; Prevention Network</article-title>. <source>Can J Clin Pharmacol</source>. <year>2010</year>;<volume>17</volume>(<issue>1</issue>):<fpage>e132</fpage>–<lpage>e164</lpage>.</citation>
</ref>
<ref id="bibr31-0883073811428377">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>CZ</given-names>
</name>
<etal/>
</person-group>. <article-title>Fetal alcohol spectrum disorders: a population based study of premature mortality rates in mothers [published online ahead of print June 28, 2011]</article-title>. <source>Matern Child Health J</source>. <comment>doi: 10.1007/s10995-011-0844-3</comment>.</citation>
</ref>
<ref id="bibr32-0883073811428377">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coles</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Kable</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Drews-Botsch</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Falek</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Early identification of risk for effects of prenatal alcohol exposure</article-title>. <source>J Stud Alcohol</source>. <year>2000</year>;<volume>61</volume>(<issue>4</issue>):<fpage>607</fpage>–<lpage>616</lpage>.</citation>
</ref>
<ref id="bibr33-0883073811428377">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Troese</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fukumizu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sallinen</surname>
<given-names>BJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Sleep fragmentation and evident for sleep debt in alcohol-exposed infants</article-title>. <source>Early Human Dev</source>. <year>2008</year>;<volume>84</volume>(<issue>9</issue>):<fpage>577</fpage>–<lpage>585</lpage>.</citation>
</ref>
<ref id="bibr34-0883073811428377">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carter</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Molteno</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Chiodo</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Viljoen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>JL</given-names>
</name>
</person-group>. <article-title>Effects of prenatal alcohol exposure on infant visual acuity</article-title>. <source>J Pediatr</source>. <year>2005</year>;<volume>147</volume>(<issue>4</issue>):<fpage>473</fpage>–<lpage>479</lpage>.</citation>
</ref>
<ref id="bibr35-0883073811428377">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobson</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Dodge</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Burden</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Klorman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>SW</given-names>
</name>
</person-group>. <article-title>Number processing in adolescents with prenatal alcohol exposure and ADHD: differences in the neurobehavioral phenotype</article-title>. <source>Alcohol Clin Exp Res</source>. <year>2011</year>;<volume>35</volume>(<issue>3</issue>):<fpage>431</fpage>–<lpage>442</lpage>.</citation>
</ref>
<ref id="bibr36-0883073811428377">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Coles</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>IE</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of prenatal alcohol exposure at school age. II. Attention and behavior</article-title>. <source>Neurotoxicol Teratol</source>. <year>1991</year>;<volume>13</volume>(<issue>4</issue>):<fpage>369</fpage>–<lpage>376</lpage>.</citation>
</ref>
<ref id="bibr37-0883073811428377">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coles</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>IE</given-names>
</name>
<name>
<surname>Platzman</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Erickson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Falek</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Effects of prenatal alcohol exposure at school age. I. Physical and cognitive development</article-title>. <source>Neurotoxicol Teratol</source>. <year>1991</year>;<volume>13</volume>(<issue>4</issue>):<fpage>357</fpage>–<lpage>367</lpage>.</citation>
</ref>
<ref id="bibr38-0883073811428377">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Connor</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Paley</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Psychiatric conditions associated with prenatal alcohol exposure</article-title>. <source>Dev Disabil Res Rev</source>. <year>2009</year>;<volume>15</volume>(<issue>3</issue>):<fpage>225</fpage>–<lpage>234</lpage>.</citation>
</ref>
<ref id="bibr39-0883073811428377">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burd</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Treatment of fetal alcohol spectrum disorders: are we ready yet?</article-title> <source>J Clin Psychopharmacol</source>. <year>2009</year>;<volume>29</volume>(<issue>1</issue>).</citation>
</ref>
<ref id="bibr40-0883073811428377">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Malley</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Nanson</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Clinical implications of a link between fetal alcohol spectrum disorder and attention-deficit hyperactivity disorder</article-title>. <source>Can J Psychiatry</source>. <year>2002</year>;<volume>47</volume>(<issue>4</issue>):<fpage>349</fpage>–<lpage>354</lpage>.</citation>
</ref>
<ref id="bibr41-0883073811428377">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Malley</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Koplin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dohner</surname>
<given-names>VA</given-names>
</name>
</person-group>. <article-title>Psychostimulant clinical response in fetal alcohol syndrome</article-title>. <source>Can J Psychiatry</source>. <year>2000</year>;<volume>45</volume>(<issue>1</issue>):<fpage>90</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr42-0883073811428377">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lupton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Burd</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Harwood</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Cost of fetal alcohol spectrum disorders</article-title>. <source>Am J Med Genet C Semin Med Genet</source>. <year>2004</year>;<volume>127C</volume>(<issue>1</issue>):<fpage>42</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr43-0883073811428377">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thanh</surname>
<given-names>NX</given-names>
</name>
<name>
<surname>Jonsson</surname>
<given-names>E.</given-names>
</name>
</person-group> <article-title>Costs of fetal alcohol spectrum disorder in Alberta, Canada</article-title>. <source>Can J Clin Pharmcol</source>. <year>2009</year>;<volume>16</volume>(<issue>1</issue>):<fpage>e80</fpage>–<lpage>e90</lpage>.</citation>
</ref>
<ref id="bibr44-0883073811428377">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>May</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Gossage</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Brooke</surname>
<given-names>LE</given-names>
</name>
<etal/>
</person-group>. <article-title>Maternal risk factors for fetal alcohol syndrome in the Western cape province of South Africa: a population-based study</article-title>. <source>Am J Public Health</source>. <year>2005</year>;<volume>95</volume>(<issue>7</issue>):<fpage>1190</fpage>–<lpage>1199</lpage>.</citation>
</ref>
<ref id="bibr45-0883073811428377">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urban</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chersich</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Fourie</surname>
<given-names>LA</given-names>
</name>
<etal/>
</person-group>. <article-title>Fetal alcohol syndrome among grade 1 schoolchildren in Northern Cape Province: prevalence and risk factors</article-title>. <source>S Afr</source> <source>Med J</source>. <year>2008</year>;<volume>98</volume>(<issue>11</issue>):<fpage>877</fpage>–<lpage>882</lpage>.</citation>
</ref>
<ref id="bibr46-0883073811428377">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Credé</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sinanovic</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Adnams</surname>
<given-names>C</given-names>
</name>
<name>
<surname>London</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>The utilization of health care services by children with foetal alcohol syndrome in the Western Cape, South Africa</article-title>. <source>Drug Alcohol Depend</source>. <year>2011</year>;<volume>115</volume>(<issue>3</issue>):<fpage>175</fpage>–<lpage>182</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>